Beck Bode LLC’s Hologic HOLX Stock Holding History

Beck Bode LLC’s Portfolio HOLX Stock Details HOLX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-6,575	Closed	-$532K	–	134
2023 Q2	$532K	Sell	6,575 -82	-1%	-$6.7K	0.13%	110
2023 Q1	$537K	Buy	+6,657	New	+$536K	0.13%	116

Other funds holding HOLX

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $23.2B AUM 40.19% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Beck Bode LLC's HOLX Position: Q3 2023 in Review

Beck Bode LLC sold out of Hologic (HOLX) in Q3 2023, closing a stake of 6,575 shares — an estimated $532K sold.

Beck Bode LLC first reported a position in HOLX in Q1 2023 and held it in 2 quarters. The position peaked at $537K in Q1 2023. 694 funds tracked by Wall St. Rank hold HOLX as of Q3 2023.

Beck Bode LLC reported no remaining Hologic position as of Q3 2023 after selling out during the quarter.
Beck Bode LLC sold 6,575 Hologic shares in Q3 2023, an estimated $532K.
Beck Bode LLC first reported a position in Hologic in Q1 2023 and held it in 2 quarters.
Beck Bode LLC's Hologic position peaked at $537K in Q1 2023.
694 funds tracked by Wall St. Rank held Hologic as of Q3 2023.

Based on Beck Bode LLC's 13F filing for Q3 2023, filed 2 Nov 2023.